Amolimogene (ZYC101a)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Amolimogene (ZYC101a), covering 2013-05-29 to 2013-05-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix [Phase 2, Phase 3]